Beta Drugs Limited held an Extraordinary General Meeting on November 12, 2024, with 16 members present, where voting procedures were discussed and managed by the Company Secretary. The meeting included appraisals of legal provisions regarding electronic voting and the appointment of a scrutinizer for transparency.